A customer reported a positive result with a sterrad® velocity¿ biological indicator (bi) after a completed sterrad® cycle.The affected load was released and used on a patient.There was no report of infection, injury or harm to patient(s) associated with this issue.Although there is no report of patient injury or harm and no prior incidents have resulted in serious injury, advanced sterilization products (asp) has determined in this situation sterility cannot be assured.Therefore, as a matter of policy asp had decided to report all incidents of positive sterrad® velocity¿ biological indicators when the loads have been released for use prior to reprocessing.
|
Asp investigation summary: the investigation included a review of the device history record (dhr), trending of lot number, system risk analysis (sra), visual analysis and retains analysis.The dhr was reviewed and the involved lot met manufacturer specifications at the time of release.No anomalies were observed that would contribute to the customer's experienced issue.Trending analysis by lot number was reviewed from 05/05/2018 to 08/30/2018 and trending was not exceeded.The sra indicates the risk associated with exposure to biohazardous, pathogenic or infectious material is "low." the sterrad® velocity bi was not returned for visual inspection.Twenty-two retains bis were subject to functional evaluation.All twenty-two bis met specification.Upon follow-up, the customer stated they were unable to provide any further details regarding the event.The assignable cause could not be verified.It is unlikely the suspected positive bi was caused by a performance issue as the retains met functional specification, dhr review found no anomalies that would contribute to a positive bi result and lot history review found trending was not exceeded in this lot.An issue with sterrad® performance is also unlikely as the cycle passed and the chemical indicator disc changed correctly.As a result, there is not an issue with product performance when used per the instructions for use (ifu).The issue will continue to be tracked and trended.Asp complaint ref #: (b)(4).
|